Targeting oncogenic KRasG13C with nucleotide-based covalent inhibitors. - Goebel L; Kirschner T; Koska S; Rai A; Janning P; Maffini S; Vatheuer H; Czodrowski P; Goody RS; Müller MP; Rauh D (ELife, 2023)